Avenue Therapeutics, Inc. Recorded Big Gain

Tue, Jan 17, 2023 at 06:57 PM
Avenue Therapeutics, Inc. Recorded Big Gain

Avenue Therapeutics, Inc. (ATXI:NASDAQ) jumped higher at $1.99, a gain of 60.5%. On Tue, Jan 17, 2023, ATXI:NASDAQ touched a New 2-Week High of $1.99. From Tue, Jan 03, 2023, the stock recorded 55.56% Up Days and 60.00% Green Days

The stock spiked on Tue, Oct 04, 2022 at $16.65 with a volume of 10M+.

About Avenue Therapeutics, Inc. (ATXI:NASDAQ)

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.